We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Topics Covered
- De novo protein design
- Snakebite envenoming & antivenom development
- Computational protein engineering
- Deep learning tools
- In vitro and in vivo validation
- Global health and democratization of drug discovery
Biography
Dr. Susana Vazquez Torres is a protein design researcher in the Department of Biochemistry at the University of Washington School of Medicine, USA, where she works in the laboratory of Prof. David Baker, the 2024 Nobel Prize in Chemistry laureate. Her work combines computational and experimental approaches to engineer novel proteins, including high-affinity binders and molecules with potential applications in diagnostics, therapeutics, and neglected diseases.
Links
Series:
Categories:
Therapeutic Areas:
External Links
Talk Citation
Vazquez Torres, S. (2026, March 31). De novo designed proteins: a breakthrough in snakebite treatment [Audio file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 18, 2026, from https://doi.org/10.69645/VRTV3682.Export Citation (RIS)
Publication History
- Published on March 31, 2026
Financial Disclosures
- Dr. Susana Vazquez Torres has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Audio Interview
De novo designed proteins: a breakthrough in snakebite treatment
Published on March 31, 2026
8 min
Other Talks in the Playlist: Research Interviews
Transcript
Please wait while the transcript is being prepared...
0:00
Interviewer: We're joined
today by Susana Vazquez Torres
to discuss her
recent Nature paper,
which was published together
with her colleagues
at the lab of Prof. David Baker,
recipient of the Nobel
Prize in chemistry in 2024.
The paper describes a
successful engineering
of the novel proteins
that are capable of
efficiently neutralizing
little snake venom toxins.
Susana, thank you so much
for joining us today.
Dr. Vazquez Torres: Thank you
so much for the invitation.
Interviewer: Can you start
by sharing with us the need
that you've identified
and the approach
that you've undertaken
to address it?
Dr. Vazquez Torres: We were
interested in working on
snakebite envenoming
because it's a huge
problem worldwide
as it leads to a big number
in mortality and morbidity,
and the current treatments
are not very good.
They address this problem.
But there are so many things
that can be improved,
and we thought that
with protein design,
we could make these
treatments much more safer,
more affordable,
and more effective.
Interviewer: What were the
key challenges in your approach
and how did you overcome them?
Dr. Vazquez Torres: One of
the big challenges that we had
was to design proteins with
high affinity and specificity.
But not only that, we also
wanted to design proteins
that were able to neutralize
toxins in vitro and in vivo.
Those are two
different challenges.
But we were very
lucky and privileged
as we used these novel
protein design methods
that are very accurate to
design these proteins.
Even if the challenge
was very big,